National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland

Heart
N F MurphyJohn J V McMurray

Abstract

To examine the epidemiology, primary care burden, and treatment of heart failure in Scotland, UK. Cross sectional data from primary care practices participating in the Scottish continuous morbidity recording scheme between 1 April 1999 and 31 March 2000. 53 primary care practices (307,741 patients). 2186 adult patients with heart failure. The prevalence of heart failure in Scotland was 7.1 in 1000, increasing with age to 90.1 in 1000 among patients > or = 85 years. The incidence of heart failure was 2.0 in 1000, increasing with age to 22.4 in 1000 among patients > or = 85 years. For older patients, consultation rates for heart failure equalled or exceeded those for angina and hypertension. Respiratory tract infection was the most common co-morbidity leading to consultation. Among men, 23% were prescribed a beta blocker, 11% spironolactone, and 46% an angiotensin converting enzyme inhibitor. The corresponding figures for women were 20% (p = 0.29 versus men), 7% (p = 0.02), and 34% (p < 0.001). Among patients < 75 years 26% were prescribed a beta blocker, 11% spironolactone, and 50% an angiotensin converting enzyme inhibitor. The corresponding figures for patients > or = 75 years were 19% (p = 0.04 versus patients < 75), 7% (p = ...Continue Reading

References

Aug 1, 1992·Journal of the American College of Cardiology·D D SchockenE A Ross
Sep 22, 1994·The New England Journal of Medicine·K L NicholT Von Sternberg
Dec 1, 1993·Mayo Clinic Proceedings·R J RodehefferD J Ballard
Feb 1, 1997·European Heart Journal·M R CowieD E Grobbee
Apr 1, 1997·American Journal of Public Health·M H Chin, L Goldman
Sep 17, 1998·Archives of Internal Medicine·K L NicholT von Sternberg
Jan 19, 1999·Archives of Internal Medicine·M SenniM M Redfield
Apr 23, 1999·European Heart Journal·M R CowieG C Sutton
May 5, 1999·Circulation·M C PetrieJ J McMurray
Nov 24, 1999·BMJ : British Medical Journal·A Bowling
Apr 27, 2000·American Heart Journal·S E SheiferK A Schulman
Sep 12, 2000·Current Cardiology Reports·M M Redfield
Mar 14, 2001·European Journal of Heart Failure·S JohanssonL A García Rodríguez
Oct 18, 2001·European Heart Journal·M C PetrieJ J McMurray
Jan 29, 2002·European Journal of Heart Failure·Christopher T C LienMarion E T McMurdo
Mar 1, 2002·Journal of the American College of Cardiology·Simon StewartJohn J V McMurray
Aug 9, 2002·European Journal of Heart Failure·Fátima CeiaUNKNOWN EPICA Investigators
Nov 30, 2002·Lancet·J G F ClelandUNKNOWN Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer

❮ Previous
Next ❯

Citations

Jul 11, 2006·BMC Family Practice·Frans J M BongersJouke van der Zee
Jan 19, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·John G F Cleland
Feb 21, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Rupert A PayneStewart W Mercer
Dec 3, 2013·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·K GuhaR Sharma
May 3, 2013·The Journal of Nutrition, Health & Aging·G GargiuloP Abete
Jan 21, 2016·Expert Review of Molecular Diagnostics·Xi ZhangChamindie Punyadeera
Oct 1, 2015·European Journal of Heart Failure·Antonio TeixeiraUNKNOWN GREAT (Global Research on Acute Conditions Team) Network
Feb 2, 2010·Respiratory Physiology & Neurobiology·Danielle M GotoNaomi K Nakagawa
Jun 22, 2010·Heart & Lung : the Journal of Critical Care·Mingming YuMeili Liu
Sep 29, 2007·Archives of Gerontology and Geriatrics·Joost H W RuttenAnton H van den Meiracker
Jun 1, 2005·Lancet·John J V McMurray, Marc A Pfeffer
Sep 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Krista L LentineDaniel C Brennan
Feb 1, 2008·Journal of Advanced Nursing·Alexander M ClarkJohn J McMurray
Mar 31, 2007·European Journal of Heart Failure·Mark C van der WelChris van Weel
Jul 10, 2007·The American Journal of Geriatric Cardiology·Miles D WithamMarion E T McMurdo
Jan 27, 2009·European Journal of Heart Failure·Nathaniel Mark HawkinsJohn J V McMurray
Jul 31, 2010·Journal of the American Geriatrics Society·Gianluca TestaPasquale Abete
May 28, 2011·European Journal of Clinical Investigation·Gianluca TestaPasquale Abete
Dec 3, 2009·European Journal of Heart Failure·Nathaniel M HawkinsJohn J V McMurray
Mar 31, 2015·Herz·F Edelmann
Aug 13, 2013·Journal of Health Economics·Emilia Simeonova
Oct 22, 2013·Archives of Cardiovascular Diseases·Philippe TuppinFred Paccaud
Apr 12, 2017·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Bosco Baron-FrancoStewart W Mercer
Jan 14, 2005·European Heart Journal·John McMurray
May 21, 2020·Journal of the American Heart Association·Min ZhaoSanne A E Peters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.